We are live on ! Find out more
NVS icon

Novartis
NVS

943 hedge funds and large institutions have $22.9B invested in Novartis in 2015 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 347 increasing their positions, 339 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

134% more call options, than puts

Call options by funds: $78.6M | Put options by funds: $33.6M

27% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 41

2% more repeat investments, than reductions

Existing positions increased: 347 | Existing positions reduced: 339

0% more funds holding

Funds holding: 939 → 943 (+4)

0.17% more ownership

Funds ownership: 9.67% → 9.84% (+0.17%)

2% less capital invested

Capital invested by funds: $23.3B → $22.9B (-$451M)

12% less funds holding in top 10

Funds holding in top 10: 69 → 61 (-8)

Holders
943
Holders Change
+4
Holders Change %
+0.43%
% of All Funds
25.41%
Holding in Top 10
61
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-11.59%
% of All Funds
1.64%
New
52
Increased
347
Reduced
339
Closed
41
Calls
$78.6M
Puts
$33.6M
Net Calls
+$44.9M
Net Calls Change
+$32.4M

Top Buyers

1
IC
Institutional Capital
Illinois
+$159M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$99.7M
3
MNA
Manning & Napier Advisors
New York
+$94.7M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$67.9M
5
Northern Trust
Northern Trust
Illinois
+$42M

Top Sellers

1
Dodge & Cox
Dodge & Cox
California
-$211M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$54.6M
3
TCIM
TIAA CREF Investment Management
New York
-$46.1M
4
Neuberger Berman Group
Neuberger Berman Group
New York
-$40.4M
5
Invesco
Invesco
Georgia
-$36.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
676
Courier Capital
New York
$440K +$1.47K +16 +0.3%
SCM
677
SOL Capital Management
Maryland
$432K – – –
SAM
678
Security Asset Management
New York
$430K – – –
GIA
679
Guyasuta Investment Advisors
Pennsylvania
$429K +$40K +436 +10%
RMDI
680
R.M. Davis Inc
Maine
$425K -$10.8K -118 -2%
AAM
681
Aureus Asset Management
Massachusetts
$425K +$206K +2,248 +87%
BBA
682
BLB&B Advisors
Pennsylvania
$420K -$51.2K -558 -10%
IWMPD
683
Integrated Wealth Management (Palm Desert)
California
$416K +$10.2K +111 +2%
SYBT
684
Stock Yards Bank & Trust
Kentucky
$415K +$38.3K +417 +10%
CIP
685
Convergence Investment Partners
Florida
$412K -$142K -1,551 -25%
WTB
686
Washington Trust Bank
Washington
$407K +$2.02K +22 +0.5%
CIA
687
Capital Investment Advisors
Georgia
$407K +$28.3K +308 +7%
OAM
688
Occidental Asset Management
California
$403K – – –
BGA
689
Belmont Global Advisors
Texas
$403K +$420K +4,576 New
MPI
690
Mairs & Power Inc
Minnesota
$401K – – –
SNT
691
Security National Trust
West Virginia
$398K – – –
LJHT
692
Laurie J. Hall Trustee
$393K +$4.59K +50 +1%
LA
693
Lau Associates
Delaware
$391K – – –
MSS
694
Mitchell Sinkler & Starr
Pennsylvania
$391K +$5.14K +56 +1%
FBT
695
First Bankers Trust
Kentucky
$388K – – –
NDSI
696
Newman Dignan & Sheerar Inc
Rhode Island
$383K +$3.03K +33 +0.8%
BP
697
Ballentine Partners
Massachusetts
$382K – – –
AIA
698
Alerus Investment Advisors
Minnesota
$379K – – –
SCM
699
Schnieders Capital Management
California
$367K +$123K +1,339 +47%
YP
700
Yellowstone Partners
Idaho
$366K +$109K +1,187 +40%
26 27
28
29 30

NVS Hedge Fund Activity: Q2 2015 in Review

943 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Novartis (NVS) for Q2 2015, worth a combined $22.9B — down 1.9% from $23.3B a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new NVS positions and 41 closed out — a net gain of 11 holders — while 347 added to existing stakes and 339 trimmed.

The largest buyer was Institutional Capital, opening a new position worth an estimated $159M. The largest seller was Dodge & Cox, cutting an estimated $211M.

  • 943 institutional investors held Novartis (NVS) as of Q2 2015, up from 939 in Q1 2015.
  • Funds reported $22.9B of Novartis stock for Q2 2015, down 1.9% quarter-over-quarter.
  • 52 funds opened new Novartis positions in Q2 2015 and 41 closed out, a net change of +11 holders.
  • The largest Novartis buyer in Q2 2015 was Institutional Capital, an estimated $159M added.
  • The largest Novartis seller in Q2 2015 was Dodge & Cox, an estimated $211M sold.

Based on aggregated 13F filings for Q2 2015.